J Korean Soc Microbiol.
2000 Apr;35(2):117-127.
Involvement of the CXC chemokines Mig and IP-10 in response to M. bovis BCG
in mice
- Affiliations
-
- 1Department of Microbiology, Chonbuk National University
Medical School, Chonju, 561-182, South Korea. hwangho@moak.chonbuk.ac.kr
Abstract
-
The non-ELR-containing CXC chemokines Mig and IP-10 have been
shown to function as chemotactic cytokines for activated T lymphocytes.
In this study, we examined the potential involvement of Mig and IP-10 in
antimycobacterial response of mice immunized or infected with M. bovis
BCG. The accumulation of Mig and IP-10 mRNA in resident peritoneal
monocytes (RPMPHI) was slightly reduced by stimulation with vBCG, and the
degree was greater for 24 hr culture even though IFN-gamma was added.
Expression of Mig, IP-10, and IFN-gamma in 24 hr delayed-type
hypersensitivity (DTH) response was stronger in vBCG-immune mice than in
the non-immune. The increase of DTH measured by foot-pad thickness
appears to be clearly related to the levels of chemokines Mig and IP10
messages and those of IFN-gamma and IL-12. Stimulation with vBCG for 2
days decreased or completely dropped the levels of Mig message in
non-immune or immune splenocytes, respectively, whereas IP-10 message was
slightly decreased in 2 days culture. Moreover, messages for IL-12 (p40)
showed similar kinetics for Mig. The levels of Mig and IP-10 mRNA during
the course of infection with BCG were not readily changed in lungs,
livers, and spleens from BCG-infected mice. Although there was no obvious
changes of Mig and IP-10 messages in the target organs during infection
process, we found that the infection progressed over the first 3 wk
before being contained by the emerging immune response suggested from
detectable amount of IFN-gamma mRNA around this time. In view of
selectivity of chemokines Mig and IP-10 for activated T cells, these data
suggest that chemokine Mig and IP-10, especially in collaboration with
IL-12 and IFN-gamma, may play a role as T cell recruiters in immune
response against mycobacterial infection.